Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
09:21am | Cullinan Therapeutics Insider Sold Shares Worth $1,796,676, According to a Recent SEC Filing | MT |
05-01 | Stifel Initiates Cullinan Oncology With Buy Rating, $40 Price Target | MT |
- Stock Market
- Equities
- CGEM Stock
- News Consolidated Gems, Inc.